Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01120782 · ClinicalTrials.gov registry record · NA

Non-dispensing Study to Check Prescription Equivalence of Two Daily Disposable Toric Contact Lens Types

A NA study of Astigmatism, sponsored by Johnson & Johnson Vision Care.

Completed
Registry status
NA
Development phase
45
Enrollment target
2
Study locations

NCT01120782 is a NA study of Astigmatism that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 45 participants, below the 105-participant average among 31 other Astigmatism trials with a reported enrollment target (57% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01120782, a NA study of Astigmatism, has completed, sponsored by Johnson & Johnson Vision Care.

COMPLETED
Registry status
NA
Development phase
45 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to determine whether the prescription determined for a new daily disposable toric contact lens will be a good match to a prescription determined for an existing brand of lens.

Conditions Studied

Interventions

  • DEVICE etafilcon A toric contact lens with new wetting agent
  • DEVICE etafilcon A toric contact lens

Study Locations (2)

Florida

  • - Jacksonville

New York

  • - New York

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2010-02-01
Est. Completion 2010-02-01
Phase NA

Sponsor

Johnson & Johnson Vision Care

142 total trials

What the Registry Record Tells You About NCT01120782

The ClinicalTrials.gov registry entry for NCT01120782 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 105-participant average among 31 other Astigmatism trials with a reported enrollment target (57% lower). The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Astigmatism appearing as the primary indexed condition, and to 2 interventions - of which etafilcon A toric contact lens with new wetting agent is the first listed.

NCT01120782 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, New York.

Frequently Asked Questions

What is clinical trial NCT01120782 about?

NCT01120782 is a clinical study titled "Non-dispensing Study to Check Prescription Equivalence of Two Daily Disposable Toric Contact Lens Types". The purpose of this study is to determine whether the prescription determined for a new daily disposable toric contact lens will be a good match to a prescription determined for an existing brand of lens.

What is the current status of trial NCT01120782?

This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2010-02-01. Estimated completion is 2010-02-01.

What conditions does trial NCT01120782 study?

This clinical trial studies the following conditions: Astigmatism.

What interventions are being tested in trial NCT01120782?

The interventions under investigation include: etafilcon A toric contact lens with new wetting agent (DEVICE), etafilcon A toric contact lens (DEVICE).

Who is sponsoring clinical trial NCT01120782?

This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01120782 being conducted?

This trial has 2 study locations across Florida, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Astigmatism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.